The Latest Breaking News from melanoma

Summary Delcath Systems (DCTH) shows strong technical buy signals, with a 53.41% gain since 1/25 and a 271.33% gain in the last year. The company focuses on liver cancer treatments, with its leading product HEPZATO KIT and ongoing FOCUS clinical trial for metastatic uveal melanoma. Barchart indicators highlight 100% technical...

No, saying you’ll “just get it cut out” isn’t the foolproof skin cancer plan you think it is.

Teddi Mellencamp cried tears of joy after learning that her latest skin check-up will not be biopsied following a two-year battle with melanoma.

Campaigners welcome Nice approval for use of Kimmtrak (tebentafusp) to treat patients with uveal melanoma

New drug avilable on the NHS could boost eye cancer patients’ survival time by months

In today’s fast-paced healthcare world, few leaders balance clinical expertise and strategic innovation as seamlessly as Dr. Clara Latorre.

For people aged 25 to 49 melanoma is the second most common form of cancer, but the risk can be reduced

One Hunter area dropped out of the top 25, but one came in.

A skin cancer survivor says workplaces and sporting clubs need to do more to protect Australians from sun damage as new data highlights skin cancer hotspots.